Penny Stock Pops On COVID-19 Vaccine Development

Inovio wants to start human trials in the U.S. by April

Managing Editor
Mar 3, 2020 at 11:22 AM
facebook X logo linkedin


As coronavirus panic grips the world, there's a scramble among drug companies to develop a vaccine as soon as possible. One such name is Inovio Pharmaceuticals Inc (NASDAQ:INO). After biotech accelerated its coronavirus vaccine development, INO's stock is up 19.2% to trade at $5.23 this morning. The company plans on starting human trials by April in the U.S., and then in Asia to follow. They are aiming to deliver one million doses by the end of 2020.

This is pacing to be INO's highest close since a Jan. 27 annual high of $5.95, when the company linked up with Beijing Advaccine Biotechnology to develop a COVID-19 vaccine. Even though the shares endured pullbacks since that peak, they were neatly contained by their 50-day moving average. 

A short squeeze is in play that could keep the wind at the equity's back. Although INO is on the short-sale restricted list today, short interest increased by 30.6% in the two most recent reporting periods. This accounts for a healthy 13.4% of the stock's total available float. 

Meanwhile, calls dominate the picture among options traders. In the last 10 days, 45,176 calls have been bought at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), compared to just 4,653 puts. However, given the amount of short interest tied up in the stock, it's possible some of this call buying could be shorts seeking an options hedge against any unexpected upside.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI